Stocks and Investing Stocks and Investing
Tue, February 16, 2021
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Initiated (UWMC) at Strong Buy and Held Target at $12 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Hartaj Singh Maintained (UTHR) at Buy with Increased Target to $275 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Chris Terry Upgraded (SQM) to Strong Buy and Increased Target to $70 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Bose George Maintained (STC) at Buy with Increased Target to $70 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (AAP) at Buy with Increased Target to $199 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (AAP) at Strong Sell with Increased Target to $157 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Jeff Garro Maintained (ACCD) at Buy with Increased Target to $60 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
John Zamparo Maintained (ACB) at Hold with Increased Target to $185 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Brian Meredith Maintained (ACGL) at Strong Buy with Increased Target to $44 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Moore Maintained (AMAT) at Hold with Increased Target to $104 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Sidney Ho Maintained (AMAT) at Strong Buy with Increased Target to $125 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Ho Maintained (AMAT) at Strong Buy with Increased Target to $140 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Yanan Zhu Initiated (BEAM) at Buy and Held Target at $145 on, Feb 16th, 2021
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (VIRT) at Sell with Increased Target to $25 on, Feb 16th, 2021
Mon, February 15, 2021
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (VRTX) at Buy and Held Target at $264 on, Feb 15th, 2021
Fri, February 12, 2021
[ 12:00 AM ] - WOPRAI
Mark Strouse Downgraded (AXON) to Hold and Increased Target to $179 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (YETI) at Buy with Increased Target to $83 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (YETI) at Hold with Increased Target to $66 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Peter Keith Maintained (YETI) at Buy with Increased Target to $95 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Wendy Nicholson Upgraded (YETI) to Strong Buy and Held Target at $91 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Todd Fowler Maintained (XPO) at Buy with Increased Target to $150 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Felix Boeschen Maintained (XPO) at Buy with Increased Target to $140 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Christian Wetherbee Maintained (XPO) at Strong Bu .. with Increased Target to $150 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (WSO) at Hold with Increased Target to $233 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Bradley Thomas Maintained (TPX) at Buy with Increased Target to $37 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (TPX) at Strong Buy with Increased Target to $42 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Robert Moskow Downgraded (THS) to Hold and Increased Target to $52 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Bill Chappell Downgraded (THS) to Hold and Decreased Target to $50 on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Thomas Wadewitz Downgraded (TFII) to Hold on, Feb 12th, 2021
[ 12:00 AM ] - WOPRAI
Jonathan Aschoff Initiated (APDN) at Strong Buy and Held Target at $480 on, Feb 12th, 2021

Jonathan Aschoff Initiated (APDN) at Strong Buy and Held Target at $480 on, Feb 12th, 2021


Published on 2024-10-27 15:38:00 - WOPRAI, Jonathan Aschoff
  Print publication without navigation


Jonathan Aschoff of Roth Capital, Initiated "Applied DNA Sciences, Inc." (APDN) at Strong Buy and Held Target at $480 on, Feb 12th, 2021.

Jonathan has made no other calls on APDN in the last 4 months.



There is 1 other peer that has a rating on APDN. Out of the 1 peers that are also analyzing APDN, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan

  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $280 on, Thursday, January 14th, 2021
Contributing Sources